id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-281039-a7q5nzwn	Rodilla, Enrique	Association of Hypertension with All-Cause Mortality among Hospitalized Patients with COVID-19	2020-09-28		.txt	text/plain	4806	246	45	Multivariate analysis showed that after adjusting for gender (males, OR: 1.5, p = 0.0001), age tertiles (second and third tertiles, OR: 2.0 and 4.7, p = 0.0001), and Charlson Comorbidity Index scores (second and third tertiles, OR: 4.7 and 8.1, p = 0.0001), hypertension was significantly predictive of all-cause mortality when this comorbidity was treated with angiotensin-converting enzyme inhibitors (ACEIs) (OR: 1.6, p = 0.002) or other than renin-angiotensin-aldosterone blockers (OR: 1.3, p = 0.001) or angiotensin II receptor blockers (ARBs) (OR: 1.2, p = 0.035). First, a previous diagnosis of HT increased the risk of all-cause death in COVID-19 patients who required hospitalization on the order of approximately 20% and independently of age and other cardiovascular comorbidities, such as HF and atrial fibrillation. Second, previous treatment with ACEIs/ARBs in hypertensive patients was not associated with a higher risk of all-cause mortality in hypertensive hospitalized COVID-19 patients compared to other antihypertensive drugs.	./cache/cord-281039-a7q5nzwn.txt	./txt/cord-281039-a7q5nzwn.txt